UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report: June 5, 2017
(Date of earliest event reported)
TENET HEALTHCARE CORPORATION
(Exact name of Registrant as specified in its charter)
| Nevada | 1-7293 | 95-2557091 | ||
| (State of Incorporation) | (Commission File Number) | (IRS Employer Identification Number) |
1445 Ross Avenue, Suite 1400
Dallas, Texas 75202
(Address of principal executive offices, including zip code)
(469)893-2200
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule14a-12 under the Exchange Act (17 CFR240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule14d-2(b) under the Exchange Act (17 CFR240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule13e-4(c) under the Exchange Act (17 CFR240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐
| Item 7.01 | Regulation FD Disclosure |
On June 5, 2017, Tenet Healthcare Corporation issued a press release announcing the pricing of the previously announced private placement offering of $830 million in aggregate principal amount of senior secured first lien notes due 2024 of Tenet, $1.040 billion in aggregate principal amount of senior secured first lien notes due 2024 of THC Escrow Corporation III (“THC Escrow Corp.”), $1.410 billion in aggregate principal amount of senior secured second lien notes due 2025 of THC Escrow Corp. and $500 million in aggregate principal amount of senior unsecured notes due 2025 of THC Escrow Corp. THC Escrow Corp. is a Delaware corporation established to issue the foregoing notes. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference.
| Item 9.01 | Financial Statements and Exhibits. |
| (a) | The following exhibit is filed as a part of this Report. |
Exhibit | Description | |
| 99.1 | Press release issued on June 5, 2017 announcing pricing of private placement offering | |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| TENET HEALTHCARE CORPORATION | ||||||||
| Date: June 5, 2017 | ||||||||
| By: | /s/ Paul A. Castanon | |||||||
| Name: | Paul A. Castanon | |||||||
| Title: | Vice President, Deputy General Counsel and Corporate Secretary | |||||||
EXHIBIT INDEX
Exhibit | Description | |
| 99.1 | Press release issued on June 5, 2017 announcing pricing of private placement offering | |